Ribosomal protein L32 pseudogene 20 (RPL32P20)

Ribosomal protein L32 pseudogene 20 (RPL32P20) is a processed pseudogene related to the functional ribosomal protein L32 gene. It does not code for a functional protein and is categorized as a pseudogene, meaning it is a DNA sequence similar to a known gene but typically non-functional due to mutations or truncation. RPL32P20 has no established function, and there is no evidence that it is involved in coding a therapeutic target, acting as a biological marker, or being implicated in disease. As with many ribosomal protein pseudogenes, RPL32P20 reflects the genome’s history of gene duplication and retrotransposition events, but unlike some rare pseudogenes that can exhibit regulatory activity, there are no data establishing such a role for RPL32P20 itself. RPL32P20 is not a protein-coding gene, nor is it a pharmacologically tractable therapeutic target. There is evidence that some ribosomal protein pseudogenes can have regulatory functions in some settings, but there is no data supporting this for RPL32P20 itself. The parental gene, RPL32, is a component of the ribosomal 60S subunit and is essential for protein synthesis, but this is not relevant to RPL32P20. A closely related pseudogene—RPL32P3—has been reported to play a regulatory role in glioma-endothelial cell biology, but this is distinct from RPL32P20. Multiple aliases exist due to naming conventions, but no functional roles have been validated. RPL32P20 is a non-functional processed pseudogene with no current evidence for direct biological, pharmacological, or disease relevance. The entry is flagged as "is_incorrect" true, since this is not a bona fide therapeutic target or protein and may be a mistaken reference.

Other names

RPL32_12_951RPL32P20

None known